KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. (KALV) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 435 transactions totaling $146.0M, demonstrating a bearish sentiment with -$28.8M in net insider flow. The most recent transaction on Feb 23, 2026 involved a sale of 1,767 shares valued at $27.5K.
KALV Insider Activity Summary
Who Is Buying KALV Stock?
No significant insider buying has been recorded for KALV in the recent period.
Who Is Selling KALV Stock?
No significant insider selling has been recorded for KALV in the recent period.
Is KalVista Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KALV is bearish with an Insider Alignment Score of 40/100 and a net flow of -$28.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
KALV Frequently Asked Questions
Understanding KALV Insider Activity
Insider trading at KalVista Pharmaceuticals, Inc. (KALV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading KALV stock, having executed 435 transactions in the past 90 days. The most active insider is Holdings A/s Novo (Executive), who has made 16 transactions totaling $28.8M.
Related Tools
Track KalVista Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at KALV file new Form 4 transactions